| アブストラクト | OBJECTIVES: Drug rash with eosinophilia and systemic symptoms (DRESS) is a rare but potentially fatal adverse drug reaction characterised by cutaneous and systemic involvement. This study aimed to analyse patients with DRESS reported through the US Food and Drug Administration Adverse Event Reporting System (FAERS). METHODS: All DRESS reports submitted to FAERS between 1 January 2003 and 13 October 2025 were extracted. Patient characteristics were analysed descriptively according to severity, sex, age group and suspected drugs. RESULTS: A total of 26 831 patients with DRESS were identified, of which 99.67% were classified as having a serious adverse reaction. Overall mortality was 6.9% (1846 deaths). Female patients were more frequently affected than male patients. Adults aged 18-64 years represented the largest group. Allopurinol, lamotrigine and vancomycin were the most frequently suspected drugs, accounting for over 30% of reports. CONCLUSIONS: DRESS remains a severe adverse drug reaction. Early recognition and continuous pharmacovigilance are essential to reduce associated morbidity and mortality. |
|---|
| ジャーナル名 | European journal of hospital pharmacy : science and practice |
|---|
| Pubmed追加日 | 2026/1/23 |
|---|
| 投稿者 | Castellana, Eleonora; Chiappetta, Maria Rachele |
|---|
| 組織名 | Hospital Pharmacy, Azienda Ospedaliero Universitaria Citta della Salute e della;Scienza di Torino, Turin, Italy ecastellana@cittadellasalute.to.it.;Scienza di Torino, Turin, Italy. |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/41571447/ |
|---|
